Prospects and challenges of induced pluripotent stem cells in equine health

Pluripotent stem cells (PSCs) hold, through the capacity to differentiate into virtually all body cell types, unprecedented promise for human and animal medicine. PSCs are naturally found in the early embryo, and in rodents and humans they can be robustly harvested and grown in culture in the form o...

Full description

Bibliographic Details
Main Authors: Francesc Xavier eDonadeu, Cristina eEsteves
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-11-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fvets.2015.00059/full
id doaj-a184667d2c1548a39800d8fb7d2902ea
record_format Article
spelling doaj-a184667d2c1548a39800d8fb7d2902ea2020-11-24T22:43:55ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692015-11-01210.3389/fvets.2015.00059167432Prospects and challenges of induced pluripotent stem cells in equine healthFrancesc Xavier eDonadeu0Cristina eEsteves1University of EdinburghUniversity of EdinburghPluripotent stem cells (PSCs) hold, through the capacity to differentiate into virtually all body cell types, unprecedented promise for human and animal medicine. PSCs are naturally found in the early embryo, and in rodents and humans they can be robustly harvested and grown in culture in the form of embryonic stem cells (ESCs), however the availability of ESCs from horses is limited. ES-like cells named induced pluripotent stem cells (iPSCs) can be derived in vitro by transcription factor-mediated reprogramming of adult cells. As such, iPSCs can be generated in a patient-specific manner providing unmatched potential for tissue transplantation and in vitro disease modelling. In humans, clinical trials using iPSC-derived cells are already taking place and the use of in vitro iPSC models has identified novel mechanisms of disease and therapeutic targets. Although to a more limited extent, iPSCs have also been generated from horses, a species in which, after humans, these cells are likely to hold the greatest potential in regenerative medicine. Before a clinical use can be envisioned, however, significant challenges will need to be addressed in relation to the robust derivation, long-term culture, differentiation and clinical safety of equine iPSCs. Towards this objective, recent studies have reported significant improvement in culture conditions and the successful derivation for the first time of functional cell types from equine iPSCs. Given the wide range of exciting applications they could have, it is hoped future research will make the biomedical promise of iPSCs a reality not only for humans but also horses.http://journal.frontiersin.org/Journal/10.3389/fvets.2015.00059/fullCell DifferentiationHorsesInduced Pluripotent Stem CellsRegenerative MedicineStem Cells
collection DOAJ
language English
format Article
sources DOAJ
author Francesc Xavier eDonadeu
Cristina eEsteves
spellingShingle Francesc Xavier eDonadeu
Cristina eEsteves
Prospects and challenges of induced pluripotent stem cells in equine health
Frontiers in Veterinary Science
Cell Differentiation
Horses
Induced Pluripotent Stem Cells
Regenerative Medicine
Stem Cells
author_facet Francesc Xavier eDonadeu
Cristina eEsteves
author_sort Francesc Xavier eDonadeu
title Prospects and challenges of induced pluripotent stem cells in equine health
title_short Prospects and challenges of induced pluripotent stem cells in equine health
title_full Prospects and challenges of induced pluripotent stem cells in equine health
title_fullStr Prospects and challenges of induced pluripotent stem cells in equine health
title_full_unstemmed Prospects and challenges of induced pluripotent stem cells in equine health
title_sort prospects and challenges of induced pluripotent stem cells in equine health
publisher Frontiers Media S.A.
series Frontiers in Veterinary Science
issn 2297-1769
publishDate 2015-11-01
description Pluripotent stem cells (PSCs) hold, through the capacity to differentiate into virtually all body cell types, unprecedented promise for human and animal medicine. PSCs are naturally found in the early embryo, and in rodents and humans they can be robustly harvested and grown in culture in the form of embryonic stem cells (ESCs), however the availability of ESCs from horses is limited. ES-like cells named induced pluripotent stem cells (iPSCs) can be derived in vitro by transcription factor-mediated reprogramming of adult cells. As such, iPSCs can be generated in a patient-specific manner providing unmatched potential for tissue transplantation and in vitro disease modelling. In humans, clinical trials using iPSC-derived cells are already taking place and the use of in vitro iPSC models has identified novel mechanisms of disease and therapeutic targets. Although to a more limited extent, iPSCs have also been generated from horses, a species in which, after humans, these cells are likely to hold the greatest potential in regenerative medicine. Before a clinical use can be envisioned, however, significant challenges will need to be addressed in relation to the robust derivation, long-term culture, differentiation and clinical safety of equine iPSCs. Towards this objective, recent studies have reported significant improvement in culture conditions and the successful derivation for the first time of functional cell types from equine iPSCs. Given the wide range of exciting applications they could have, it is hoped future research will make the biomedical promise of iPSCs a reality not only for humans but also horses.
topic Cell Differentiation
Horses
Induced Pluripotent Stem Cells
Regenerative Medicine
Stem Cells
url http://journal.frontiersin.org/Journal/10.3389/fvets.2015.00059/full
work_keys_str_mv AT francescxavieredonadeu prospectsandchallengesofinducedpluripotentstemcellsinequinehealth
AT cristinaeesteves prospectsandchallengesofinducedpluripotentstemcellsinequinehealth
_version_ 1725693934864171008